EUCTR2014-003986-11-ES
Active, not recruiting
Phase 1
Prospective, double-blinded, randomized clinical trial to evaluate the potential benefitial effect of resveratrol for preventing the ovarian hyperstimulation syndrome. - The role of resveratrol for preventing the ovarian hyperstimulation syndrome
IVI Madrid0 sites70 target enrollmentApril 27, 2015
DrugsResveratrol
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- IVI Madrid
- Enrollment
- 70
- Status
- Active, not recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Egg donors who meet the following criteria:
- •1\. Number of follicles (\>12 mm) \> o \= 21 in the last scan previous ovum pick\-up.
- •2\. Number of retrieved oocytes \> o \=21\.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 70
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Exclusión criteria for egg donation: \>35 years, polycystic ovary syndrome, endometriosis, severe systematic pathology, positive serologies for BHV, CHV o HIV, or altered karyotype.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Prospective, randomized, double-blinded clinical trial on remifentanil for analgesia and sedation of ventilated neonates and infants - RAPIP-PilotstudieMeanwhile it is widely accepted, that ventilated newborns and infants should receive analgesia and sedation for ethical and medical reasons. In this context fentanyl belongs to the mosten often used opioids, with the important disadvantage of prolonged depression of respiratory drive after discontinuation of the infusion.In this clinical trial ventilated term newborns and infants (<60 days) receive either remifentanil or fentanyl for analgesia and sedation.EUCTR2005-003516-29-DEniversität zu Köln
Active, not recruiting
Phase 1
clinical study on the efficacy of infiltrative echo-guided therapy with hyaluronic acid (500-730 KDa) (HYALGAN®) versus saline solution in the conservative treatment of Achilles tendinopathy. Subjects will be randomly assigned to one of these two groups of treatment. Both evaluator and patients are unaware of the treatment assigned. In the open label extension, patients with persistent pain can receive a second cycle of Hyalgan.Achilles tendinopathyTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2013-004117-40-ITFidia Farmaceutici SpA54
Active, not recruiting
Phase 1
ATVAC (Lactobacilli Therapeutic Vaccine study)Bacterial vaginosis (Nugent score 4 or above)Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2013-002918-12-HUAmvac Kft
Completed
Not Applicable
Prospective, double-blind, randomized controlled trial on efficacy of lidocaine injection method during esophageal endoscopic submucosal dissection.early esophageal cancerJPRN-UMIN000032804Saiseikai Nakatsu Hospital50
Active, not recruiting
Not Applicable
Prospective,Double-Blind Randomized Clinical Trial on the Effects of Early Administration of Prolonged Methylprednisolone Therapy in early Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) - NDAcute Lung Injury (ALI) - Acute Respiratory Distress Syndrome (ARDS)MedDRA version: 6.1Level: PTClassification code 10049874EUCTR2007-005901-23-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI400